These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38744440)

  • 1. Obesity, liver steatosis and metabolic syndrome: The hidden enemies in transfusion-dependent thalassaemia.
    Padeniya P; Premawardhena A
    Br J Haematol; 2024 Jul; 205(1):28-29. PubMed ID: 38744440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver steatosis in patients with transfusion-dependent thalassaemia.
    Ricchi P; Pistoia L; Positano V; Spasiano A; Casini T; Putti MC; Borsellino Z; Cossu A; Messina G; Keilberg P; Fatigati C; Costantini S; Renne S; Peritore G; Cademartiri F; Meloni A
    Br J Haematol; 2024 Jun; 204(6):2458-2467. PubMed ID: 38685724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver fibrosis in young patients with transfusion-dependent thalassaemia (TDT), understanding the role of steatosis.
    Ricchi P
    Br J Haematol; 2023 Feb; 200(4):399-400. PubMed ID: 36301125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Iron Overload Between Age Groups Using Magnetic Resonance Imaging and Its Correlation with Iron Profile in Transfusion-dependent Thalassemia.
    Wahidiyat PA; Iskandar SD; Sekarsari D
    Acta Med Indones; 2018 Jul; 50(3):230-236. PubMed ID: 30333273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and Risk Factors for Cardiac and Liver Iron Overload in Adults with Thalassemia in Malaysia.
    Ngim CF; Lee MY; Othman N; Lim SM; Ng CS; Ramadas A
    Hemoglobin; 2019 Mar; 43(2):95-100. PubMed ID: 31179787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron burden and endocrine complications in transfusion-dependent thalassemia patients In Sarawak, Malaysia: a retrospective study.
    Chow LC; Lee BS; Tang SO; Loh EW; Ng SC; Tan XY; Ahmad Noordin MN; Ong GB; Chew LC
    Med J Malaysia; 2024 May; 79(3):281-287. PubMed ID: 38817060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of liver steatosis on the ability of serum ferritin levels to be predictive of liver iron concentration in non-transfusion-dependent thalassaemia patients.
    Ricchi P; Meloni A; Spasiano A; Costantini S; Pepe A; Cinque P; Filosa A
    Br J Haematol; 2018 Mar; 180(5):721-726. PubMed ID: 29363758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron Chelation Therapy as a Modality of Management.
    Aydinok Y
    Hematol Oncol Clin North Am; 2018 Apr; 32(2):261-275. PubMed ID: 29458731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between steatosis and liver damage in transfusion-dependent beta thalassaemia patients.
    Padeniya P; Ediriweera D; De Silva AP; Niriella M; Premawardhena A
    Br J Haematol; 2023 Feb; 200(4):517-523. PubMed ID: 36194160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limitations of serum ferritin to predict liver iron concentration responses to deferasirox therapy in patients with transfusion-dependent thalassaemia.
    Porter JB; Elalfy M; Taher A; Aydinok Y; Lee SH; Sutcharitchan P; El-Ali A; Han J; El-Beshlawy A
    Eur J Haematol; 2017 Mar; 98(3):280-288. PubMed ID: 27859648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron overload across the spectrum of non-transfusion-dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions.
    Porter JB; Cappellini MD; Kattamis A; Viprakasit V; Musallam KM; Zhu Z; Taher AT
    Br J Haematol; 2017 Jan; 176(2):288-299. PubMed ID: 27917462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of endocrine complications in transfusion dependent thalassemia in Hospital Pulau Pinang: A pilot study.
    Lee KT; Lim SL; Goh AS
    Med J Malaysia; 2020 Jan; 75(1):33-37. PubMed ID: 32008017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance imaging during management of patients with transfusion-dependent thalassemia: a single-center experience.
    Karakas Z; Yilmaz Y; Bayramoglu Z; Karaman S; Aydogdu S; Karagenc AO; Tugcu D; Dursun M
    Radiol Med; 2018 Aug; 123(8):572-576. PubMed ID: 29663188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron overload in non-transfusion-dependent thalassemia: association with genotype and clinical risk factors.
    Tantiworawit A; Charoenkwan P; Hantrakool S; Choeyprasert W; Sivasomboon C; Sanguansermsri T
    Int J Hematol; 2016 Jun; 103(6):643-8. PubMed ID: 27052211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of HFE Gene Mutations With Serum Ferritin Level and Heart and Liver Iron Overload in Patients With Transfusion-dependent Beta-Thalassemia.
    Zekavat OR; Zareian Jahromi M; Haghpanah S; Kargar Jahromi Z; Cohan N
    J Pediatr Hematol Oncol; 2021 Jan; 43(1):e26-e28. PubMed ID: 32925401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deferasirox for managing iron overload in people with thalassaemia.
    Bollig C; Schell LK; Rücker G; Allert R; Motschall E; Niemeyer CM; Bassler D; Meerpohl JJ
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD007476. PubMed ID: 28809446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thalassaemia is paradoxically associated with a reduced risk of in-hospital complications and mortality in COVID-19: Data from an international registry.
    El-Battrawy I; Longo F; Núñez Gil IJ; Abumayyaleh M; Gianesin B; Estrada V; Aparisi Á; Arroyo-Espliguero R; Balocco M; Barella S; Beccaria A; Bonetti F; Casale M; De Michele E; Denotti AR; Fidone C; Fortini M; Gamberini MR; Graziadei G; Lisi R; Massa A; Marcon A; Rubinski B; Miano M; Motta I; Pinto VM; Piperno A; Mariani R; Putti MC; Quota A; Ribersani M; Marziali M; Roberti D; Rosso R; Tartaglione I; Vitucci A; Voi V; Zecca M; Romero R; Marouneld C; Fernández-Rozas I; Espejo C; Marhaeni W; Garcia Aguado M; Cappellini MD; Perrotta S; De Franceschi L; Piga A; Forni GL; Akin I
    J Cell Mol Med; 2022 May; 26(9):2520-2528. PubMed ID: 35355397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative susceptibility mapping in combination with water-fat separation for simultaneous liver iron and fat fraction quantification.
    Lin H; Wei H; He N; Fu C; Cheng S; Shen J; Wang B; Yan X; Liu C; Yan F
    Eur Radiol; 2018 Aug; 28(8):3494-3504. PubMed ID: 29470640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease.
    Voskaridou E; Douskou M; Terpos E; Papassotiriou I; Stamoulakatou A; Ourailidis A; Loutradi A; Loukopoulos D
    Br J Haematol; 2004 Sep; 126(5):736-42. PubMed ID: 15327528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic iron in pediatric transfusion-dependent beta-thalassemia patients: A longitudinal MRI study.
    Meloni A; Pistoia L; Putti MC; Longo F; Corigliano E; Ricchi P; Rossi V; Casini T; Righi R; Renne S; Peritore G; Barbuto L; Positano V; Cademartiri F
    Pediatr Blood Cancer; 2024 May; 71(5):e30923. PubMed ID: 38385860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.